Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019

Author:

Leung Tiffany H.12,El Helali Aya3,Wang Xiaofei4,Ho James C.1ORCID,Pang Herbert24ORCID

Affiliation:

1. Department of Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China

2. School of Public Health, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China

3. Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China

4. Department of Biostatistics and Bioinformatics, School of Medicine Duke University Durham North Carolina USA

Abstract

AbstractBackgroundDespite the growth in primary cancer (PC) survivors, the trends and disparities in this population have yet to be comprehensively examined using competing risk analysis. The objective is to examine trends in time to second primary cancer (SPC) and to characterize age, sex, and racial disparities in time‐to‐SPC.MethodsA retrospective analysis was conducted based on Surveillance, Epidemiology, and End Results (SEER). Two datasets for this study are (1) the discovery dataset with patients from SEER‐8 (1990–2019) and (2) the validation dataset with patients from SEER‐17 (2000–2019), excluding those in the discovery dataset. Patients were survivors of lung, colorectal, breast (female only), and prostate PCs.ResultsThe 5‐year SPC cumulative incidences of lung PC increased from 1990 to 2019, with the cumulative incidence ratio being 1.73 (95% confidence intervals [CI], 1.64–1.82; p < 0.001). Age disparities among all PCs remained from 2010 to 2019, and the adjusted HRs (aHRs) of all PCs were above 1.43 when those below 65 were compared with those 65 and above. Sex disparity exists among colorectal and lung PC survivors. Racial disparities existed among non‐Hispanic (NH) Black breast PC survivors (aHR: 1.11; 95% CI: 1.07–1.17; p < 0.001). The types of SPC vary according to PC and sex.ConclusionsOver the past three decades, there has been a noticeably shortened time‐to‐SPC among lung PC survivors. This is likely attributed to the reduced number of lung cancer deaths due to advancements in effective treatments. However, disparities in age, sex, and race still exist, indicating that further effort is needed to close the gap.

Funder

University of Hong Kong

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference37 articles.

1. Group UCSW.US Cancer Statistics Data Visualizations Tool Based on 2021 Submission Data (1999–2019): US Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute.2022. Centers for Disease Control and Prevention and National Cancer Institute.

2. Cancer treatment and survivorship statistics, 2019

3. Trends in the risk and burden of second primary malignancy among survivors of smoking‐related cancers in the United States

4. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

5. Cancer Prevention for Survivors: Incidence of Second Primary Cancers and Sex Differences—A Population-Based Study from an Italian Cancer Registry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3